000			01686 a2200457 4500
005			20250513212105.0
264		0	_c20000724
008			200007s 0 0 eng d
022			_a1078-8956
024	7		_a10.1038/76243 _2doi
040			_aNLM _beng _cNLM
100	1		_aTrojan, A
245	0	0	_aImmunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. _h[electronic resource]
260			_bNature medicine _cJun 2000
300			_a667-72 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aCells, Cultured
650	0	4	_aComputational Biology
650	0	4	_aEpitopes, T-Lymphocyte _ximmunology
650	0	4	_aHLA-A2 Antigen _ximmunology
650	0	4	_aHistocompatibility Antigens Class I _ximmunology
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Variable Region _ximmunology
650	0	4	_aImmunoglobulins _ximmunology
650	0	4	_aLeukemia, Lymphoid _ximmunology
650	0	4	_aLymphoma, Follicular _ximmunology
650	0	4	_aLymphoma, Mantle-Cell _ximmunology
650	0	4	_aLymphoma, Non-Hodgkin _ximmunology
650	0	4	_aMultiple Myeloma _ximmunology
650	0	4	_aPeptides _ximmunology
650	0	4	_aT-Lymphocytes, Cytotoxic _xcytology
700	1		_aSchultze, J L
700	1		_aWitzens, M
700	1		_aVonderheide, R H
700	1		_aLadetto, M
700	1		_aDonovan, J W
700	1		_aGribben, J G
773	0		_tNature medicine _gvol. 6 _gno. 6 _gp. 667-72
856	4	0	_uhttps://doi.org/10.1038/76243 _zAvailable from publisher's website
999			_c10787093 _d10787093